Methods and compositions for reducing neuronal cell death

Abstract

Methods and compositions involving a class of boron-protected phenylphosphine agents having increased cell permeability and having improved chemical stability for treating or for preventing neuronal cell death-related diseases or conditions in a human or a non-human animal.

1 . A method for protecting a neuronal cell from cell death, the method comprising the step of:
 exposing one or more neuronal cells to an effective amount of a pharmaceutical composition having a formula of:   
       
         
           
           
               
               
           
         
         wherein one of R 1  to R 3  is an aryl group or a substituted aryl group and two of R 1  to R 3  are CH 2 CH 2 COOCH 3 ; and 
         a pharmaceutically acceptable carrier. 
       
     
     
         2 . (canceled) 
     
     
         3 . The method of  claim 1 , wherein the aryl group is a phenyl group and the substituted aryl group is a substituted phenyl group. 
     
     
         4 . The method of  claim 1 , wherein the substituted aryl group comprises an aromatic ring directly linked to the phosphorus. 
     
     
         5 - 8 . (canceled) 
     
     
         9 . The method of  claim 1 , wherein the compound defined by the formula is bis(3-propionic acid methyl ester)phenylphosphine borane complex. 
     
     
         10 . The method of  claim 1 , wherein the neuronal cells are neurons. 
     
     
         11 . The method of  claim 10 , wherein the neurons are retinal ganglion cells. 
     
     
         12 . The method of  claim 1 , wherein the neuronal cells are human or non-human animal neuronal cells. 
     
     
         13 . The method of  claim 1 , wherein the neuronal cells are protected in vivo in a human or in a non-human animal. 
     
     
         14 - 18 . (canceled) 
     
     
         19 . A pharmaceutical composition comprising:
 a compound having a formula of   
       
         
           
           
               
               
           
         
         wherein one of R 1 -R 3  is an aryl group or a substituted aryl group and two of R 1 -R 3  are CH 2 CH 2 COOCH 3 ; and 
         a pharmaceutically acceptable carrier.